|
|
|
Corporate Profile: Alexion
Pharmaceuticals
| Summary: |
| Alexion
Pharmaceuticals is focused on the development of
proprietary immunoregulatory technologies for the
treatment of cardiovascular, autoimmune and neurologic
diseases. |
| Address (HQ): |
352 Knotter Drive
Cheshire, CT 06410 |
| Phone
#'s (HQ): |
| Main |
(203) 272-2596 |
| Human
Resources |
not known |
| Investor
Relations |
(203) 272-2596 |
| Fax
#'s (HQ): |
| Main |
(203) 271-8198 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Financial
information: |
| ALXN |
| Number
of employees: |
| 1,800 |
| Issued United States patents: |
| Issued U.S.
patents 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
